3NC
ONXX

300 North Capital’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

300 North Capital’s Portfolio ONXX Stock Details ONXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-16,955
Closed -$1.47M – 129
2013
Q2 		$1.47M Buy
+16,955
New +$1.56M 0.57% 74

Other funds holding ONXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

300 North Capital's ONXX Position: Q3 2013 in Review

300 North Capital sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q3 2013, closing a stake of 16,955 shares — an estimated $1.47M sold.

300 North Capital first reported a position in ONXX in Q2 2013 and held it in 1 quarter. The position peaked at $1.47M in Q2 2013. 258 funds tracked by Wall St. Rank hold ONXX as of Q3 2013.

  • 300 North Capital reported no remaining ONYX PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • 300 North Capital sold 16,955 ONYX PHARMACEUTICALS INC shares in Q3 2013, an estimated $1.47M.
  • 300 North Capital first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • 300 North Capital's ONYX PHARMACEUTICALS INC position peaked at $1.47M in Q2 2013.
  • 258 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q3 2013.

Based on 300 North Capital's 13F filing for Q3 2013, filed 12 Nov 2013.